[Pe-012] English Poster Session 012

[Pe-012-1] Efficacy and Safety of Eculizumab in a Phase 3 Trial in Guillain-Barre Syndrome

Satoshi Kuwabara¹, Sonoko Misawa¹, Hirokazu Ishida², Tomoyuki Kasuya², Erik Kupperman³, Lin Qun³, Glen Frick³ (1.Department of Neurology, Chiba University, Japan, 2.Alexion Pharma GK, Japan, 3.Alexion, AstraZeneca Rare Disease, USA)